Invention Grant
US09149448B2 Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
有权
使用半胱胺产品治疗非酒精性脂肪性肝炎（NASH）的方法
- Patent Title: Methods of treating non-alcoholic steatohepatitis (NASH) using cysteamine products
- Patent Title (中): 使用半胱胺产品治疗非酒精性脂肪性肝炎（NASH）的方法
-
Application No.: US13608134Application Date: 2012-09-10
-
Publication No.: US09149448B2Publication Date: 2015-10-06
- Inventor: Ranjan Dohil , Jerry Schneider
- Applicant: Ranjan Dohil , Jerry Schneider
- Applicant Address: US CA Oakland
- Assignee: The Regents of the University Of California
- Current Assignee: The Regents of the University Of California
- Current Assignee Address: US CA Oakland
- Agency: Gavrilovich, Dodd & Lindsey LLP
- Agent Joseph R. Baker, Jr.
- Main IPC: A01N33/08
- IPC: A01N33/08 ; A61K31/145 ; A61K9/48 ; A61K45/06
Abstract:
The disclosure relates, in general, to treatment of fatty liver disorders comprising administering compositions comprising cysteamine products. The disclosure provides administration of enterically coated cysteamine compositions to treat fatty liver disorders, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH).
Public/Granted literature
- US20130183351A1 METHODS OF TREATING NON-ALCOHOLIC STEATOHEPATITIS (NASH) USING CYSTEAMINE PRODUCTS Public/Granted day:2013-07-18
Information query
